Form 4: Bio Green Med Director Converts Warrants, Sells Shares

Bio Green Med Solution Director Yap Kim Choy exchanged various Series Warrants for 467,535 shares of common stock and disposed of 28,540 shares on November 5, 2025.

Summary

• Yap Kim Choy, a Director and 10% Owner of Bio Green Med Solution, Inc. (BGMS), reported transactions on November 5, 2025.
• Disposed of 28,540 shares of common stock at a price of $1.70 per share.
• Acquired 467,535 shares of common stock through the exchange of warrants.
• The warrant exchange involved 218,000 Series A Common Stock Warrants (strike price $7.65), 218,000 Series B Common Stock Warrants (strike price $9.00), and 31,535 Series C Common Stock Warrants (strike price $10.20).
• Following these transactions, Yap Kim Choy beneficially owns 467,535 shares of common stock directly.
• All derivative securities (warrants) previously held are now reported as 0.

Sentiment

Score: 6

Explanation: The conversion of a significant number of warrants into common stock by a key insider can be viewed as a positive sign of commitment and belief in the company's future. However, the simultaneous disposal of a smaller block of common stock introduces a slight ambiguity, preventing a strongly positive sentiment.

Positives

• Conversion of a significant number of warrants into common stock by a director and 10% owner, potentially signaling long-term confidence in the company's equity.
• Simplification of the insider's ownership structure by converting complex derivative securities into direct common stock holdings.

Negatives

• Disposal of 28,540 shares of common stock by a director and 10% owner, which could be interpreted negatively by the market.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The filing details transactions by Yap Kim Choy, a Director and 10% Owner of Bio Green Med Solution, Inc., which are considered related party transactions due to his insider status.

Stakeholder Impact

• Shareholders: The conversion of warrants into common stock increases the direct equity stake of a significant insider, potentially aligning their interests more closely with other shareholders. The disposal of shares, while smaller, might raise questions about the insider's short-term outlook.

Key Dates

Keywords

Bio Green Med Solution, BGMS, Form 4, insider trading, common stock, warrants, director, 10% owner, stock transaction, beneficial ownership